SCHEMBL4246819

SCHEMBL4246819

O=C(CCl)NCc1cc(Cl)ccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.54
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 2/20 0.49
ERCC1 P07992 4/20 0.48
ERCC4 Q92889 4/20 0.48
JAK2 O60674 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HDAC3 O15379 1/20 0.46
POLB P06746 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
F2 P00734 1/20 0.45
TEAD1 P28347 1/20 0.45
YAP1 P46937 1/20 0.45
TEAD4 Q15561 1/20 0.45
TEAD2 Q15562 1/20 0.45
CNR1 P21554 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1143282 0.86 ALDH1A1 (0.64) P2RX7ALDH1A1ERCC1ERCC4NPC1
SCHEMBL3185618 0.85 ERCC1 (0.54) KMT2AALDH1A1MEN1ERCC1ERCC4
SCHEMBL4074085 0.85 HTT (0.55) P2RX7KMT2AALDH1A1MEN1ERCC1
SCHEMBL7934893 0.85 P2RX7 (0.53) P2RX7KMT2AALDH1A1MEN1ERCC1
SCHEMBL3557506 0.82 P2RX7 (0.53) P2RX7KMT2AALDH1A1MEN1ERCC1
SCHEMBL5797584 0.81 P2RX7 (0.49) P2RX7KMT2AALDH1A1MEN1ERCC1
SCHEMBL626586 0.81 CYP2C9 (0.58) P2RX7KMT2AALDH1A1MEN1ERCC1
SCHEMBL23565221 0.80 P2RX7 (0.59) P2RX7ALDH1A1ERCC1ERCC4JAK2
SCHEMBL23565573 0.80 ERCC1 (0.58) P2RX7ALDH1A1ERCC1ERCC4JAK2
SCHEMBL4074083 0.80 SMN1; SMN2 (0.52) P2RX7KMT2AALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834514-A INHIBITORS OF INTERLEUKIN-1B CONVERTING ENZYME, TREATMENT OF INFLAMMATORY AND IMMUNE BASED DISEASES OF THE LUNGS, CENTRAL NERVOUS SYSTEM AND CONNECTIVE TISSUES VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-11-10 US claimed
EP-0758891-A4 HALOMETHYL AMIDES AS IL-1-g(b) PROTEASE INHIBITORS SANOFI WINTHROP INC (US) 1997-12-03 EP claimed
EP-0758891-A1 HALOMETHYL AMIDES AS IL-1$g(b) PROTEASE INHIBITORS SANOFI WINTHROP, INC. (US) 1997-02-26 EP claimed
WO-1995029672-A1 HALOMETHYL AMIDES AS IL-1β PROTEASE INHIBITORS SANOFI WINTHROP, INC. (US) 1995-11-09 WO claimed
WO-2009125191-A1 BENZENE DERIVATIVES UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2009-10-15 WO disclosed
US-5834514-A INHIBITORS OF INTERLEUKIN-1B CONVERTING ENZYME, TREATMENT OF INFLAMMATORY AND IMMUNE BASED DISEASES OF THE LUNGS, CENTRAL NERVOUS SYSTEM AND CONNECTIVE TISSUES VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-11-10 US disclosed